Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
|Product Number||List Price||Your Price||Quantity|
You successfully added item(s) to your cart
OsteoSense® 800 is a targeted fluorescent in vivo bisphosphonate imaging agent. OsteoSense 800 images areas of microcalcifications and bone remodeling and enables imaging of bone growth and resorption. OsteoSense 800 fluorescent imaging agent at a wavelenth at 800 nm, can be used to measure the effects of therapeutic stimulation of bone growth. This agent can also be used to characterize bone remodeling associated with animal models of arthritis. OsteoSense 800 enables in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.
Disclaimer: For laboratory use only. This product is intended for animal research only and not for use in humans.
|Fluorescent Agent Type||Targeted|
|One Unit Contains||10 doses|
|Optical Imaging Classification||Fluorescence Imaging|
|Product Brand Name||OsteoSense|
|Therapeutic Area||Atherosclerosis, Oncology/Cancer, Arthritis|
|Unit Size||1 Vial (10 doses)|
|Wave Length||800 nm|
|Resource Type||File Name||File Format|
|Brochure||FMT Fluorescence Tomography in vivo Imaging Systems||PDF 1 MB|
|Brochure||In Vivo Imaging Agents Brochure||PDF 2 MB|
|Technical Note||OsteoSense 800 (Protocol)||PDF 215 KB|
|Technical Note||OsteoSense® 800 (Data Sheet)||PDF 176 KB|
|Poster||Imaging of Cathepsin K activity in rodent models of bone turnover and soft tissue calcification||PDF 966 KB|
|Citations Library||View peer reviewed publications using PerkinElmer's In Vivo Imaging Reagents||Link|